Venclexta (venetoclax)

pCPA File Number: 21564
Negotiation Status:
Negotiations were not pursued
Indication(s):
Acute myeloid leukemia (AML) Newly diagnosed in patients who are 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy (In combination with low-dose cytarabine)
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
PC0239-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: